Published in J Neurol on April 07, 2011
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study. Diabetes Care (2012) 1.17
Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers. J Neurol (2013) 0.86
Evaluation of proxy tests for SFSN: evidence for mixed small and large fiber dysfunction. PLoS One (2012) 0.81
Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients. J Diabetes Investig (2016) 0.80
Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS One (2013) 0.80
Renal nerve ultrastructural alterations in short term and long term experimental diabetes. BMC Neurosci (2014) 0.79
Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases. Medicine (Baltimore) (2013) 0.78
Nociception at the diabetic foot, an uncharted territory. World J Diabetes (2015) 0.77
NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy. PLoS One (2016) 0.76
In Patients with an α-Galactosidase A Variant, Small Nerve Fibre Assessment Cannot Confirm a Diagnosis of Fabry Disease. JIMD Rep (2015) 0.75
Accuracy of a Rapid and Non-Invasive Method for the Assessment of Small Fiber Neuropathy Based on Measurement of Electrochemical Skin Conductances. Front Endocrinol (Lausanne) (2016) 0.75
Automated PGP9.5 immunofluorescence staining: a valuable tool in the assessment of small fiber neuropathy? BMC Res Notes (2016) 0.75
Acquired neuropathies. J Neurol (2013) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain (2006) 5.55
Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry (1976) 4.13
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes (2007) 2.95
Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain (2004) 2.45
Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med (2008) 2.44
Diabetic neuropathy--a review. Nat Clin Pract Neurol (2007) 2.32
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care (2002) 1.99
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90
Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve (2001) 1.85
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 1.63
Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology (1999) 1.62
Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology (2001) 1.60
Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol (2007) 1.51
Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve (2007) 1.44
Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol (2008) 1.40
A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology (1993) 1.36
Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett (2008) 1.31
Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve (2007) 1.30
The effect of age and gender on epidermal nerve fiber density. Neurology (2004) 1.29
Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol (2003) 1.24
Influence of aging on thermal and vibratory thresholds of quantitative sensory testing. J Peripher Nerv Syst (2005) 1.21
How do we selectively activate skin nociceptors with a high power infrared laser? Physiology and biophysics of laser stimulation. Neurophysiol Clin (2003) 1.20
Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials. Clin Neurophysiol (2000) 1.12
Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol (2007) 1.00
Determinants of epidermal nerve fiber density in normal individuals. Muscle Nerve (2006) 0.97
Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med (1998) 0.95
Laser-evoked potentials: normative values. Clin Neurophysiol (2005) 0.90
Influence of thermode size for detecting heat pain dysfunction in a capsaicin model of epidermal nerve fiber loss. Pain (2001) 0.89
Correlation of quantitative tests of nerve and target organ dysfunction with skin immunohistology in leprosy. Brain (1998) 0.89
The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers. Clin Neurophysiol (2010) 0.87
Early detection of nerve damage and repair in diabetic neuropathy. Nat Clin Pract Neurol (2008) 0.83
Pre-perceptual pain sensory responses (N1 component) in type 1 diabetes mellitus. Neuroreport (2002) 0.80
An adaptive procedure for routine measurement of light-touch sensitivity threshold. Muscle Nerve (2010) 0.80
Single-trial detection of human brain responses evoked by laser activation of Adelta-nociceptors using the wavelet transform of EEG epochs. Neurosci Lett (2004) 0.79
Early detection of small-fiber neuropathy in diabetes: a laser-induced pain somatosensory-evoked potentials and pupillometric study. Diabetes Care (2002) 0.78
Trigeminal small-fibre dysfunction in patients with diabetes mellitus: a study with laser evoked potentials and corneal reflex. Clin Neurophysiol (2000) 0.77
The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol (2010) 2.33
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol (2011) 2.19
Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med (2002) 2.12
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol (2008) 1.88
Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation (2002) 1.78
Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res (2002) 1.68
Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci (2006) 1.54
Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy. Brain (2012) 1.52
Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J Nucl Med (2007) 1.48
Assessment of lipid-lowering treatment in France--the CEPHEUS study. Arch Cardiovasc Dis (2008) 1.44
Susac syndrome in four male patients. Retina (2006) 1.41
Automatic colorimetric calibration of human wounds. BMC Med Imaging (2010) 1.36
Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 1.34
Autophagy in cardiovascular disease. Trends Mol Med (2007) 1.31
Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol (2007) 1.31
Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain (2006) 1.27
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res (2008) 1.27
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci (2008) 1.23
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice. Behav Brain Res (2009) 1.19
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin Chem Lab Med (2006) 1.15
Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods. J Nucl Med (2007) 1.14
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation (2013) 1.13
Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor. Toxicol Appl Pharmacol (2008) 1.08
Thermal detection thresholds of Aδ- and C-fibre afferents activated by brief CO2 laser pulses applied onto the human hairy skin. PLoS One (2012) 1.05
Gene expression profiling of apoptosis-related genes in human atherosclerosis: upregulation of death-associated protein kinase. Arterioscler Thromb Vasc Biol (2002) 1.05
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics. J Neural Transm (Vienna) (2011) 1.04
Pre-treatment with capsaicin in a rat osteoarthritis model reduces the symptoms of pain and bone damage induced by monosodium iodoacetate. Eur J Pharmacol (2010) 1.02
Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex (2009) 1.01
Differences in behavioural test battery performance between mice with hippocampal and cerebellar lesions. Behav Brain Res (2006) 1.01
The effects of A-fiber pressure block on perception and neurophysiological correlates of brief non-painful and painful CO2 laser stimuli in humans. Eur J Pain (2003) 0.99
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls. J Cereb Blood Flow Metab (2013) 0.98
Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a. J Neurol (2009) 0.98
P2X currents in peritoneal macrophages of wild type and P2X4 -/- mice. Immunol Lett (2007) 0.97
IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology (2007) 0.96
Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity. Eur J Pain (2009) 0.96
[Hypertension, insulin resistance and chronic kidney disease in type 2 diabetes patients from South Kivu, DR Congo]. Nephrol Ther (2010) 0.96
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Impaired trunk stability in individuals at high risk for Parkinson's disease. PLoS One (2012) 0.95
In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation (2002) 0.94
Western blot analysis of a limited number of cells: a valuable adjunct to proteome analysis of paraffin wax-embedded, alcohol-fixed tissue after laser capture microdissection. J Pathol (2004) 0.94
Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. J Clin Lipidol (2012) 0.93
Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons. FASEB J (2011) 0.92
Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis (2008) 0.92
Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers. Eur J Nucl Med Mol Imaging (2007) 0.91
Reduction of Abeta levels in the Sprague Dawley rat after oral administration of the functional gamma-secretase inhibitor, DAPT: a novel non-transgenic model for Abeta production inhibitors. Curr Pharm Des (2006) 0.90
How many response levels do children distinguish on faces scales for pain assessment? Eur J Pain (2008) 0.90
Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial. Mult Scler (2010) 0.89
Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines. Vaccine (2013) 0.88
Expression of human amyloid precursor protein in rat cortical neurons inhibits calcium oscillations. J Neurosci (2009) 0.88
Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon. Vasc Health Risk Manag (2013) 0.88
The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers. Clin Neurophysiol (2010) 0.87
The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas? Neurology (2012) 0.87
Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus. Cardiovasc Diabetol (2011) 0.86
Affective associative learning modifies the sensory perception of nociceptive stimuli without participant's awareness. Pain (2003) 0.86
Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers. J Clin Pharmacol (2014) 0.86
Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young. Clin Neurol Neurosurg (2012) 0.86
Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis (2011) 0.85
In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity. Eur Heart J (2005) 0.85
Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation? Circulation (2003) 0.85
Involuntary orientation of attention to unattended deviant nociceptive stimuli is modulated by concomitant visual task difficulty. Evidence from laser evoked potentials. Clin Neurophysiol (2005) 0.85
The characteristics of LTP induced in hippocampal slices are dependent on slice-recovery conditions. Learn Mem (2006) 0.85
Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes. Diabetes Care (2003) 0.85
CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway. Liver Int (2003) 0.84
Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation. Diabetes Care (2007) 0.84
A behavioral and pharmacological validation of the acetone spray test in gerbils with a chronic constriction injury. Anesth Analg (2005) 0.83
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study. Neuropharmacology (2012) 0.83
Overexpression of the anti-apoptotic caspase-2 short isoform in macrophage-derived foam cells of human atherosclerotic plaques. Am J Pathol (2003) 0.83
Impaired appetitively as well as aversively motivated behaviors and learning in PDE10A-deficient mice suggest a role for striatal signaling in evaluative salience attribution. Neurobiol Learn Mem (2010) 0.83
Quantitation of chronic and acute treatment effects on neuronal network activity using image and signal analysis: toward a high-content assay. J Biomol Screen (2013) 0.83
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study. Neuroepidemiology (2013) 0.82
Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus. Neurocrit Care (2013) 0.82
Electrophysiological correlates of attentional orientation in humans to strong intensity deviant nociceptive stimuli, inside and outside the focus of spatial attention. Neurosci Lett (2003) 0.82
Peripheral and central determinants of a nociceptive reaction: an approach to psychophysics in the rat. PLoS One (2008) 0.82
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery. BMC Neurol (2011) 0.82
Modulation of perception and neurophysiological correlates of brief CO2 laser stimuli in humans using concurrent large fiber stimulation. Somatosens Mot Res (2003) 0.82
Phenotypic variation of autosomal-dominant corticobasal degeneration. Eur Neurol (2012) 0.81
Fatal rhinocerebral mucormycosis with intracavernous carotid aneurysm and thrombosis: a late complication of transsphenoidal surgery? Acta Neurol Belg (2012) 0.81
Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability during cholesterol lowering in rabbits. J Cardiovasc Pharmacol (2003) 0.81
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects. Br J Clin Pharmacol (2011) 0.81
The F-actin content of multiple myeloma cells as a measure of their migration. Ann N Y Acad Sci (2002) 0.81
Shielding cognition from nociception with working memory. Cortex (2012) 0.80
An adaptive procedure for routine measurement of light-touch sensitivity threshold. Muscle Nerve (2010) 0.80
Functional MRI brain imaging studies using the Contact Heat Evoked Potential Stimulator (CHEPS) in a human volunteer topical capsaicin pain model. J Pain Res (2011) 0.80
Non-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD. Diab Vasc Dis Res (2011) 0.80
Pharmacological characterization of cultivated neuronal networks: relevance to synaptogenesis and synaptic connectivity. Cell Mol Neurobiol (2014) 0.80
Intravascular thermography: Immediate functional and morphological vascular findings. Eur Heart J (2004) 0.80
Measure of experimental pain using Rasch analysis. Eur J Pain (2006) 0.80
Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome. J Neurochem (2012) 0.79
Psychophysics of a nociceptive test in the mouse: ambient temperature as a key factor for variation. PLoS One (2012) 0.79